Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
| |
 |
Articles |
|
|
Air Cargo Trends in a Pandemic World.
Previous predictions in pharmaceutical transportation trends, highlighting declining air passenger numbers and air freight demand increasing, have been pandemic propelled.
|
|
|
|
|
| |
| |
|
|
Fill and Finish in Clinical Development: Getting it Right from the Start.
Regardless of size, pharma and biotech companies alike encounter numerous challenges in the process of fill and finish of drugs for clinical development, including any subsequent scale-up steps.
|
|
|
| |
|
COVID-19 Impact on Pharmaceutical Industry Comment.
Reflecting on the beginning of the COVID-19 outbreak 12 months ago, it is clear that those pharma companies who responded early to the warning signs like ChargePoint Technology were most effective....
|
|
 |
|
| |
|
Latest News & Press Releases |
|
| |
|
|
FedEx Extends Support and Donates Second Charter Flight to Deliver Critical Aid to India.
FedEx Express announced the arrival of a second dedicated charter flight carrying critical medical aid to India. This is part of the company's continuous relief...
|
|
|
| |
|
Dr. Reddy's Laboratories Announces Launch of the Sputnik V vaccine inthe Indian Market.
Dr. Reddy's Laboratories announced that the first consignment of imported doses of the Sputnik V vaccine that landed in India on 1stMay, 2021...
|
|
 |
|
| | |
|
| |
| |
|
|
Bharat Biotechs Covaxin approved for phase 2/3 trials on children.
The Drugs Controller General of India has approved Bharat Biotech's COVID-19 vaccine Covaxin for phase II/III clinical trial on those aged between two to 18 years.
|
|
|
| |
|
The U.S. plans to send 20 million vaccination doses to help world battle the virus.
President Biden, heeding widespread calls to step up his response to the pandemic's surge abroad, said on that his administration would send 20 million doses...
|
|
|
|
| | |
|
| |
| |
|
|
Memo Therapeutics AG Antibodies Against SARS-CoV-2 Show Efficacy Against British and South African Variant.
Memo Therapeutics announced that MTX-COVAB, its human derived antibody against SARS-CoV-2, the virus that causes COVID-19, has shown efficacy against...
|
|
|
| |
|
India's Biological E. to produce J&J COVID-19 vaccine.
India's Biological E. will produce the Johnson & Johnson COVID-19 vaccine alongside its own candidate, which could boost the country’s overall ..
|
|
|
|
|
